The kinase NIK as a therapeutic target in multiple myeloma.
about
NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in miceDendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cellsKinase inhibitors as potential agents in the treatment of multiple myeloma.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.PPM1A is a RelA phosphatase with tumor suppressor-like activity.NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.The NF-κB Activating Pathways in Multiple Myeloma.
P2860
Q35570169-F48273BF-14BB-49F2-A2D3-791F5D63E300Q36332123-D5D143F6-34AF-4243-95C1-8E185A8A10E7Q37697253-B4C1DCC8-A278-47F8-82C4-2FD128213846Q38014834-54FAE8AC-438D-408B-A90E-9E797FF0E314Q39132976-0243D3AC-864E-4744-BA58-44B8C0532F43Q54247368-C0781B69-73D1-4E23-831D-B887D64A8346Q55461027-E3B2757B-9563-4981-ADC0-CC87976D423CQ55657825-2171E64C-E1DB-4E87-97DC-D857A15107A1
P2860
The kinase NIK as a therapeutic target in multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The kinase NIK as a therapeutic target in multiple myeloma.
@en
The kinase NIK as a therapeutic target in multiple myeloma.
@nl
type
label
The kinase NIK as a therapeutic target in multiple myeloma.
@en
The kinase NIK as a therapeutic target in multiple myeloma.
@nl
prefLabel
The kinase NIK as a therapeutic target in multiple myeloma.
@en
The kinase NIK as a therapeutic target in multiple myeloma.
@nl
P2860
P1476
The kinase NIK as a therapeutic target in multiple myeloma.
@en
P2093
Sandra Gardam
P2860
P304
P356
10.1517/14728222.2011.548861
P407
P50
P577
2011-01-05T00:00:00Z